RxDoctor Payments Data

Melissa Caplan, PA

Medical · Marietta, GANPI 1174501274

Payments from drug & device makers

$1,229in general payments, 2019–2025

Across 65 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$190
  • Novartis$186
  • Johnson & Johnson$129
  • Pfizer$110
  • GSK$81
  • Pharmacyclics LLC, An Abbvie Company$73
  • plus $460 from 19 others

What the payments were for

  • Food & beverage$1,21699%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,229 in reported general payments places this provider in the 55th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$51,440
Medicare patients
356
Services billed
880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide28$428,339
IbrancePalbociclib17$252,599
EliquisApixaban55$40,071
Abiraterone Acetate18$21,817
Exemestane35$4,883
Anastrozole45$857
Letrozole56$756
Hydroxyurea21$668
Tamoxifen Citrate19$581
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine21$521
Dexamethasone24$350
Ondansetron Hcl41$267
Alendronate Sodium39$244
Mirtazapine12$233
Gabapentin30$229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbRevlimid$23$428,33928 claims
PfizerIbrance, Eliquis$110$292,67072 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 950 medical providers in Georgia.

Other medical in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →